NDAINTRAVENOUSSOLUTION
Approved
Mar 2011
Lifecycle
LOE Approaching
Competitive Pressure
30/100
Clinical Trials
29
Mechanism of Action
Magnetic Resonance Contrast Activity
Pharmacologic Class:
Gadolinium-based Contrast Agent
Indications (1)
Clinical Trials (5)
MR Image Synthesis With Low Gadobutrol Dose and AI
Started Jun 2023
60 enrolled
Enhancing Brain Lesions
A Study Called GUS to Understand How Much of the Contrast Agent Gadavist is Used and How Much is Wasted in Two Different Containers (Single-dose Vials and Imaging Bulk Packages ) in a Real-world Setting
Started Nov 2022
1,602 enrolled
Contrast Enhancement in Magnetic Resonance Imaging
Effect on Body Movement and Mental Skills in Patients Who Received Gadolinium-based Contrast Media for Magnetic Resonance Examination Multiple Times Within 5 Years
Started Mar 2021
2,076 enrolled
Motor FunctionCognitive FunctionContrast Media
Dotarem vs Gadobutrol Contrast for Breast MRI
Started Mar 2021
300 enrolled
Breast Diseases
Comparison of Gadovist 75% Standard Dose to Dotarem at Full Standard Dose
Started Nov 2018
157 enrolled
Magnetic Resonance Imaging